Market Research Logo

Global mRNA Vaccines & Therapeutics Sales Market Report 2018

Global mRNA Vaccines & Therapeutics Sales Market Report 2018

This report studies the mRNA Vaccines & Therapeutics market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the mRNA Vaccines & Therapeutics market by product type and applications.

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The major players in global mRNA Vaccines & Therapeutics market include
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of mRNA Vaccines & Therapeutics in these regions, from 2020 to 2030 (forecast), covering
North America
Europe
Asia Pacific
South America
Middle East and Africa

On the basis on the end users/applications, this report covers
Infectious Disease
Cancer
Other


1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Global mRNA Vaccines & Therapeutics Market by Applications/End Users
1.2.1 Global mRNA Vaccines & Therapeutics Expenses Comparison by Applications (2013-2025)
1.2.2 Infectious Disease
1.2.3 Cancer
1.3 Global mRNA Vaccines & Therapeutics Revenue (2020-2030)
1.4 Global mRNA Vaccines & Therapeutics Market by Regions
1.4.1 Global mRNA Vaccines & Therapeutics Revenue Comparison by Regions (2020-2030)
1.4.2 North America mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.3 Europe mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.4 Asia Pacific mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.5 South America mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
1.4.6 Middle East and Africa mRNA Vaccines & Therapeutics Status and Prospect (2020-2030)
2 Global mRNA Vaccines & Therapeutics Competition by Players and Application
2.1 Global mRNA Vaccines & Therapeutics Market Competition by Players
2.2 Global mRNA Vaccines & Therapeutics Expenses by Regions
2.3 Global mRNA Vaccines & Therapeutics Expenses by Application
3 North America mRNA Vaccines & Therapeutics
3.1 North America mRNA Vaccines & Therapeutics Expense (2013-2018)
3.2 North America mRNA Vaccines & Therapeutics Expense and Market Share by Players
3.3 North America mRNA Vaccines & Therapeutics Expense and Market Share by Applications
4 Europe mRNA Vaccines & Therapeutics
4.1 Europe mRNA Vaccines & Therapeutics Expenses (2013-2018)
4.2 Europe mRNA Vaccines & Therapeutics Expenses and Market Share by Players
4.3 Europe mRNA Vaccines & Therapeutics Expenses and Market Share by Applications
5 Major Cancer Analysis
5.1 Colorectal Cancer
5.1.1 Colorectal Cancer Introduction
5.1.2 Introduction of the Number of Patients with Colorectal Cancer
5.2 Lung Cancer
5.2.1 Lung Cancer Introduction
5.2.2 Introduction of the Number of Patients with Lung Cancer
5.3 Pancreatic Cancer
5.3.1 Pancreatic Cancer Introduction
5.3.2 Introduction of the Number of Patients with Pancreatic Cancer
5.4 Breast Cancer
5.4.1 Breast Cancer Introduction
5.4.2 Introduction of the Number of Patients with Breast Cancer
5.5 Prostate Cancer
5.5.1 Prostate Cancer Introduction
5.5.2 Introduction of the Number of Patients with Prostate Cancer
5.6 Other Cancer
6 Analysis of mRNA Vaccines & Therapeutics Industry Key Manufacturers
6.1 Moderna Therapeutics
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Expenses, R&D Share
6.2 CureVac
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Expenses, R&D Share
6.3 RaNa Therapeutics (Translate Bio)
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Expenses, R&D Share
6.4 BioNTech
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Expenses, R&D Share
6.5 Sangamo Therapeutics
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Expenses, R&D Share
6.6 Argos Therapeutics
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Expenses, R&D Share
6.7 In-Cell-Art
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Expenses, R&D Share
6.8 eTheRNA
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Expenses, R&D Share
6.9 Ethris
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Expenses, R&D Share
6.10 Tiba Biotechnology
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Expenses, R&D Share
7 Company Profiles
7.1 Companies with mRNA Programs
7.1.1 Alexion Pharmaceuticals
7.1.2 Vertex Pharmaceuticals
7.1.3 Ultragenyx Pharmaceutical
7.2 Companies focus on mRNA Delivery
7.2.1 Acuitas Therapeutics
7.2.2 Silence Therapeutics
7.2.3 Arcturus Therapeutics
8 Major Pharmaceutical Companies with mRNA Programs
8.1 Boehringer Ingelheim
8.2 Novartis
8.3 Merck
8.4 AstraZeneca
8.5 Roche
8.6 Sanofi
8.7 Takeda
8.8 Johnson & Johnson
8.9 Bayer
8.10 ZIOPHARM Oncology
8.11 MaxCyte
8.12 Casebia Therapeutics
8.13 Intellia Therapeutics
9 Pipeline Analysis of mRNA Vaccines & Therapeutics Key Manufacturers
9.1 Pipeline Analysis of mRNA Vaccines & Therapeutics
9.2 Main Pipeline Product Analysis
9.2.1 IVAC-Mutanome
9.2.2 FixVax
9.2.3 CV8102
9.2.4 CV7201
9.2.5 AGS-004
9.2.6 MRT5005 & MRT5201
9.2.7 SB-FIX & SB-318 & SB-913
9.2.8 mRNA-1647
9.2.9 mRNA-4157
9.2.10 mRNA-1653
10 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
10.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
10.1.1 Clinical Phase Costs
10.1.2 Capitalized Costs
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Other Costs Analysis
10.2.4 Manufacturing Expenses
10.3 Comparison of Production Processes for Traditional, mRNA and DNA vaccines
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 mRNA Vaccines & Therapeutics Discovery and Development Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 DNA/mRNA Advantages Over Traditional Vaccines
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Pipeline Analysis of Global RNAi for Therapeutic Key Manufacturers
13.2 Consumer Needs/Customer Preference Change
13.2.1 Considerations for both Early and Late Phase Clinical Trials
13.2.2 Considerations for Early Phase Clinical Trials
13.2.3 Considerations for Late Phase Clinical Trials
13.3 Economic/Political Environmental Change
14 Global mRNA Vaccines & Therapeutics Market Forecast (2020-2030)
14.1 Global mRNA Vaccines & Therapeutics Revenue Forecast (2020-2030)
14.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast by Regions (2020-2030)
14.2.1 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.2.2 North America mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.2.3 Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.2.4 Asia Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.2.5 South America mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.2.6 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2020-2030)
14.3 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2020-2030)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
16.4 Author List
List of Tables and Figures
Figure Product Picture of mRNA Vaccines & Therapeutics
Table Scope of Clinical mRNA Applications
Figure Global Expenses Market Share of mRNA Vaccines & Therapeutics by Applications in 2017
Figure Infectious Disease Examples
Figure Cancer Examples
Figure Global mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Global Market mRNA Vaccines & Therapeutics Revenue (M USD) Comparison by Regions 2020-2030
Figure North America mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Europe mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Asia Pacific mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure South America mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Figure Middle East and Africa mRNA Vaccines & Therapeutics Revenue (M USD) and Growth Rate (2020-2030)
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) of Key Players (2017-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure 2017 Global mRNA Vaccines & Therapeutics Expenses Market Share by Players
Figure 2018 Global mRNA Vaccines & Therapeutics Expenses Market Share by Players
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) and Market Share by Regions (2013-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Regions (2013-2018)
Figure Expenses Market Share of mRNA Vaccines & Therapeutics by Regions (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Expenses Market Share by Regions in 2017
Table Global mRNA Vaccines & Therapeutics Expenses (M USD) by Application (2013-2018)
Table Global mRNA Vaccines & Therapeutics Expenses Market Share by Application (2013-2018)
Figure Expenses Market Share of mRNA Vaccines & Therapeutics by Application (2013-2018)
Figure Global mRNA Vaccines & Therapeutics Expenses Market Share by Application in 2017
Figure North America mRNA Vaccines & Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table North America mRNA Vaccines & Therapeutics Expenses (M USD) by Players (2017-2018)
Table North America mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure North America mRNA Vaccines & Therapeutics Expenses Market Share by Players in 2017
Table North America mRNA Vaccines & Therapeutics Expenses (M USD) by Applications (2013-2018)
Table North America mRNA Vaccines & Therapeutics Expenses Market Share by Applications (2013-2018)
Figure North America mRNA Vaccines & Therapeutics Expenses Market Share by Applications in 2017
Figure Europe mRNA Vaccines & Therapeutics Expenses (M USD) and Growth Rate (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses (M USD) by Players (2017-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses Market Share by Players (2017-2018)
Figure Europe mRNA Vaccines & Therapeutics Expenses Market Share by Players in 2017
Table Europe mRNA Vaccines & Therapeutics Expenses (M USD) by Applications (2013-2018)
Table Europe mRNA Vaccines & Therapeutics Expenses Market Share by Applications (2013-2018)
Figure Europe mRNA Vaccines & Therapeutics Expenses Market Share by Applications in 2017
Top 20 Countries Highest Incidence of Colorectal Cancer in 2016
Top 20 Countries Highest Incidence of Lung Cancer in 2016
Figure Percent of New Cases by Age Group: Lung Cancer
Figure Percent of Deaths by Age Group: Lung Cancer
Top 20 Countries Highest Incidence of Pancreatic Cancer in 2016
Top 20 Countries Highest Incidence of Breast Cancer in 2016
Figure Percent of New Cases by Age Group: Prostate Cancer
Figure Percent of Deaths by Age Group: Prostate Cancer
Figure Estimated Prostate Cancer Incidence Worldwide in 2016
Information about World Cancer Statistics for the Most Common Cancers (excluding non-melanoma Skin Cancer) in 2016
Table Moderna Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Picture of Moderna Therapeutics
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Moderna Therapeutics 2017-2018
Table CureVac Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of CureVac
Figure mRNA Vaccines & Therapeutics Product Information of CureVac
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of CureVac 2017-2018
Table Translate Bio Company Profile
Figure mRNA Vaccines & Therapeutics Product Picture of Translate Bio
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Translate Bio 2017-2018
Table BioNTech Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of BioNTech
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of BioNTech 2017-2018
Table Sangamo Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Picture of Sangamo Therapeutics
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Sangamo Therapeutics 2017-2018
Table Argos Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Picture of Argos Therapeutics
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Argos Therapeutics 2017-2018
Table In-Cell-Art Company Profile
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of In-Cell-Art 2017-2018
Table eTheRNA Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of eTheRNA
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of eTheRNA 2017-2018
Table Ethris Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of Ethris
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Ethris 2017-2018
Table Tiba Biotechnology Company Profile
Figure mRNA Vaccines & Therapeutics Product Picture of Tiba Biotechnology
Table mRNA Vaccines & Therapeutics Expenses (M USD), R&D Share of Tiba Biotechnology 2017-2018
Table Alexion Pharmaceuticals Company Profile
Table Vertex Pharmaceuticals Company Profile
Table Ultragenyx Pharmaceutical Company Profile
Table Acuitas Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of Acuitas Therapeutics
Table Silence Therapeutics Company Profile
Table Table Product Information
Table Arcturus Therapeutics Company Profile
Table Product Information
Table Boehringer Ingelheim Company Profile
Table Novartis Company Profile
Table Merck Company Profile
Table AstraZeneca Company Profile
Table Roche Company Profile
Table Sanofi Company Profile
Table Takeda Company Profile
Table Johnson & Johnson Company Profile
Table Bayer Company Profile
Table ZIOPHARM Oncology Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of ZIOPHARM Oncology
Table MaxCyte Company Profile
Table Casebia Therapeutics Company Profile
Figure mRNA Vaccines & Therapeutics Product Information of Casebia Therapeutics
Table Intellia Therapeutics Company Profile
Table Product Information
Table Pipeline Analysis mRNA Vaccines & Therapeutics
Figure IVAC-Mutanome Pipeline
Figure FixVax Pipeline
Figure CV8102 Pipeline
Figure CV7201 Pipeline
Figure CV7201 Pipeline
Figure MRT5005 & MRT5201 Pipeline
Figure SB-FIX Pipeline
Figure SB-318 & SB-913 Pipeline
Figure mRNA-1647 Pipeline
Figure mRNA-4157 Pipeline
Figure mRNA-1653 Pipeline
Figure Typical Phases from Research to the Market for a Cancer Vaccine Candidate
Table Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure USA Labor Cost Analysis 2015-2018
Figure Cost of Employing a Factory Worker
Figure Europe Labor Cost Analysis 2015-2018
Figure Germany Labor Cost Analysis 2015-2018
Figure UK Labor Cost Analysis 2015-2018
Figure France Labor Cost Analysis 2015-2018
Figure Italy Labor Cost Analysis 2015-2018
Figure Monthly Minimum Wages in Asia 2016
Figure China Labor Costs 2015-2018
Figure Japan Average Monthly Wages 2015-2018
Figure Global Electricity Prices by Select Countries in 2017 (in U.S. Dollars per Kilowatt Hour)
Table Average Price of Electricity to Ultimate Customers 2007-2018
Figure Electricity Prices for Household Consumers in 2017
Table China Cost of Electricity 2017 (PER KWH)
Figure Comparison of Production Processes for Traditional, mRNA and DNA Vccines
Figure Differences between Traditional, mRNA and DNA Vaccines
Figure History of Vaccine Development
Figure Differences between Traditional, MRNA and DNA Vaccines (Delivery)
Figure mRNA Vaccines & Therapeutics Discovery and Development Analysis
Table Major Buyers of mRNA Vaccines & Therapeutics
Figure Setting Pricing Policy
Figure Picture of RNAi for Therapeutic
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Table Therapeutic Areas Analysis of Global RNAi Technology Key Manufacturers
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 Annual Average
Figure USA GDP 2008-2016 (Billion USD)
Figure USA GDP Growth Rate Change 2015-2018
Figure EU GDP 2008-2016 (Billion USD)
Figure EU GDP Growth Rate Change 2015-2018
Figure Germany GDP 2008-2016 (Billion USD)
Figure Germany GDP Growth Rate 2015-2018
Figure UK GDP 2008-2016 (Billion USD)
Figure UK GDP Growth Rate 2015-2018
Figure Italy GDP 2008-2016 (Billion USD)
Figure Italy GDP Growth Rate 2015-2018
Figure France GDP 2008-2016 (Billion USD)
Figure France GDP Growth Rate 2015-2018
Figure Japan GDP 2008-2016 (Billion USD)
Figure Japan GDP Growth Rate 2015-2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report